2020 Leadership Journey Project: Supporting women leaders by increasing gender balance among grantees within the Vaccine Development & Surveillance team at the Gates Foundation.
Vivian Hsu has been at the Bill & Melinda Gates Foundation since 2016 and is currently the Deputy Director of Strategy, Planning and Management for the Vaccine Development and Surveillance team. In this capacity, she manages the business operations for the team whose core focus is investments in new vaccine manufacturing technologies, infectious disease surveillance, epidemic preparedness and control, HPV and Polio product development, and other vaccine development innovations. Her portfolio of work spans the spectrum of driving day-to-day business management to leading major cross-foundation initiatives.
Vivian’s career has centered around the healthcare industry, beginning as a consultant in the US pharmaceutical industry prior to moving to Hong Kong to join McKinsey and Company. There, she spent the majority of her three years developing China market strategies for various multinational pharmaceutical and hospital corporations. In 2011, she entered the University of Pennsylvania Wharton of Business Healthcare Management program, where she focused on understanding the complexities of healthcare delivery. After graduation, Vivian joined Evolent Health, a population health services company. With her team, she built Evolent’s payer partnership practice which worked with hospitals to design value-based care infrastructure and negotiate population-based contracts with insurance companies and CMS in the US government.
Vivian graduated from Yale University in 2006 with a degree in political science and East Asian studies.